Latest News about FDA
Recent news which mentions FDA
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?
June 17, 2025
From Benzinga
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
June 16, 2025
From Benzinga
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
June 13, 2025
From Benzinga
From Benzinga
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
June 13, 2025
From Benzinga
From Benzinga
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
June 11, 2025
From Benzinga
American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance
June 10, 2025
From Benzinga
From Benzinga
From Benzinga
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
June 06, 2025
From Benzinga
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
June 06, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming
June 03, 2025
Tickers
CYBN
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free